Selective p38 activation in human non-small cell lung cancer.

The mitogen-activated protein kinase (MAPK) pathways transmit signals from the cell membrane to the nucleus. Activation of MAPK cascades may play a role in malignant transformation. We hypothesized that enhanced expression of one or more of these pathways would occur in human lung cancers. Using Western blot analysis of tissue homogenates from resected non- small cell lung cancers and matched non-neoplastic lung tissue, we determined that only activated p38 was consistently increased in tumor compared with normal tissue. In vitro kinase assays confirmed that the levels of activated MAPK correlated with the activity of the enzymes, and immunohistochemical analysis confirmed the cellular localization of the activated MAPKs. We incubated a lung cancer cell line in a hypoxic chamber to simulate the hypoxic environment in solid lung tumors, but found no increase in p38 activation. Contrary to our expectations, ERK and JNK, the MAPK pathways traditionally associated with cell growth and perhaps malignant transformation, were not consistently activated in the human lung tumor samples. However, p38, a MAPK usually associated with stress responses, growth arrest, and apoptosis, was activated in all of the human lung cancer samples, suggesting an additional role for this pathway in malignant cell growth or transformation.

[1]  S. Deventer,et al.  NF-kappaB, p38 MAPK and JNK are highly expressed and active in the stroma of human colonic adenomatous polyps , 2001, Oncogene.

[2]  T. Patel,et al.  Involvement of p38 mitogen‐activated protein kinase signaling in transformed growth of a cholangiocarcinoma cell line , 2001, Hepatology.

[3]  B. Evers,et al.  Downregulation of mitogen-activated protein kinases in human colon cancers. , 2000, Anticancer research.

[4]  T. Lee,et al.  Molecular and genetic aspects of lung cancer. , 2000, American journal of respiratory and critical care medicine.

[5]  J. Bonventre,et al.  Transfection of constitutively active mitogen-activated protein/extracellular signal-regulated kinase kinase confers tumorigenic and metastatic potentials to NIH3T3 cells. , 2000, Cancer Research.

[6]  W. Lang,et al.  A dominant role for the c-Jun NH2-terminal kinase in oncogenic ras-induced morphologic transformation of human lung carcinoma cells. , 2000, Cancer Research.

[7]  D. Spandidos,et al.  Activation of the ras genes in malignant and premalignant colorectal tumors. , 1998, Oncology reports.

[8]  E. Goldsmith,et al.  A constitutively active and nuclear form of the MAP kinase ERK2 is sufficient for neurite outgrowth and cell transformation , 1998, Current Biology.

[9]  Channing J Der,et al.  Increasing complexity of Ras signaling , 1998, Oncogene.

[10]  Y. Bang,et al.  Increased MAPK activity and MKP-1 overexpression in human gastric adenocarcinoma. , 1998, Biochemical and biophysical research communications.

[11]  C. Der,et al.  Increasing Complexity of the Ras Signaling Pathway* , 1998, The Journal of Biological Chemistry.

[12]  M. Wigler,et al.  Signaling pathways in Ras-mediated tumorigenicity and metastasis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[13]  D. Brenner,et al.  Analysis of Signaling Protein Kinases in Human Colon or Colorectal Carcinomas , 1998, Digestive Diseases and Sciences.

[14]  M. Cobb,et al.  Identification of Substrates and Regulators of the Mitogen-activated Protein Kinase ERK5 Using Chimeric Protein Kinases* , 1998, The Journal of Biological Chemistry.

[15]  J. Gutkind The Pathways Connecting G Protein-coupled Receptors to the Nucleus through Divergent Mitogen-activated Protein Kinase Cascades* , 1998, The Journal of Biological Chemistry.

[16]  D. Brenner,et al.  In vivo activation of mitogen-activated protein kinases in rat intestinal neoplasia. , 1997, Gastroenterology.

[17]  G. Nuovo,et al.  Hyperexpression of mitogen-activated protein kinase in human breast cancer. , 1997, The Journal of clinical investigation.

[18]  H. Greulich,et al.  Mek1 Phosphorylation Site Mutants Activate Raf-1 in NIH 3T3 Cells* , 1996, The Journal of Biological Chemistry.

[19]  M. Loda,et al.  Expression of mitogen-activated protein kinase phosphatase-1 in the early phases of human epithelial carcinogenesis. , 1996, The American journal of pathology.

[20]  M. Cobb,et al.  ERK3 Is a Constitutively Nuclear Protein Kinase (*) , 1996, The Journal of Biological Chemistry.

[21]  O Yoshida,et al.  Constitutive activation of mitogen-activated protein (MAP) kinases in human renal cell carcinoma. , 1995, Cancer research.

[22]  M. J. Atten,et al.  Decreased MAP kinase activity in human gastric adenocarcinoma. , 1995, Biochemical and biophysical research communications.

[23]  W. Rom,et al.  Detection of K-ras oncogene mutations in bronchoalveolar lavage fluid for lung cancer diagnosis. , 1995, Journal of the National Cancer Institute.

[24]  M. Karin The Regulation of AP-1 Activity by Mitogen-activated Protein Kinases (*) , 1995, The Journal of Biological Chemistry.

[25]  W. Rom,et al.  Increased prevalence of K-ras oncogene mutations in lung adenocarcinoma. , 1995, Cancer research.

[26]  N. Ahn,et al.  Transformation of mammalian cells by constitutively active MAP kinase kinase. , 1994, Science.

[27]  C. Marshall,et al.  Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells , 1994, Cell.

[28]  A. Brunet,et al.  Constitutively active mutants of MAP kinase kinase (MEK1) induce growth factor-relaxation and oncogenicity when expressed in fibroblasts. , 1994, Oncogene.

[29]  S. Pelech,et al.  MAP kinases: charting the regulatory pathways. , 1992, Science.

[30]  T. Pechacek,et al.  Smoking-attributable cancer mortality in 1991: is lung cancer now the leading cause of death among smokers in the United States? , 1991, Journal of the National Cancer Institute.

[31]  Daniel S. Miller,et al.  Annual report to the nation on the status of cancer, 1973-1996, with a special section on lung cancer and tobacco smoking. , 1999, Journal of the National Cancer Institute.

[32]  N. Ahn,et al.  Signal transduction through MAP kinase cascades. , 1998, Advances in cancer research.

[33]  M. J. Atten,et al.  MAPK activity is down-regulated in human colon adenocarcinoma: correlation with PKC activity. , 1996, Anticancer research.

[34]  A. Chambers,et al.  Ras-responsive genes and tumor metastasis. , 1993, Critical reviews in oncogenesis.

[35]  F. McCormick,et al.  Regulators and effectors of ras proteins. , 1991, Annual review of cell biology.